Clinical Trial Update: Optimizing IV Gentamicin in JEB [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on optimizing intravenous gentamicin for Junctional Epidermolysis Bullosa across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Junctional Epidermolysis Bullosa

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: University of Southern California | Conditions: Junctional Epidermolysis Bullosa | Phase 1, Phase 2 | Status: UNKNOWN